Bio-Path Holdings Statistics
Total Valuation
BPTH has a market cap or net worth of $3.77 million. The enterprise value is $3.66 million.
| Market Cap | 3.77M |
| Enterprise Value | 3.66M |
Important Dates
The next estimated earnings date is Tuesday, August 13, 2024, before market open.
| Earnings Date | Aug 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BPTH has 2.08 million shares outstanding. The number of shares has increased by 62.56% in one year.
| Shares Outstanding | 2.08M |
| Shares Change (YoY) | +62.56% |
| Shares Change (QoQ) | +35.36% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 1.15% |
| Float | 1.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.43
| Current Ratio | 0.43 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -1,037.30%.
| Return on Equity (ROE) | -1,037.30% |
| Return on Assets (ROA) | -337.80% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.40M |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.09% in the last 52 weeks. The beta is 0.28, so BPTH's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -93.09% |
| 50-Day Moving Average | 2.18 |
| 200-Day Moving Average | 6.57 |
| Relative Strength Index (RSI) | 41.56 |
| Average Volume (20 Days) | 114,886 |
Short Selling Information
The latest short interest is 145,386, so 6.99% of the outstanding shares have been sold short.
| Short Interest | 145,386 |
| Short Previous Month | 82,583 |
| Short % of Shares Out | 6.99% |
| Short % of Float | 8.79% |
| Short Ratio (days to cover) | 0.05 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.25M |
| Pretax Income | -13.96M |
| Net Income | -13.96M |
| EBITDA | -13.78M |
| EBIT | -13.96M |
| Earnings Per Share (EPS) | -$26.11 |
Balance Sheet
The company has $188,000 in cash and $85,000 in debt, giving a net cash position of $103,000 or $0.05 per share.
| Cash & Cash Equivalents | 188,000 |
| Total Debt | 85,000 |
| Net Cash | 103,000 |
| Net Cash Per Share | $0.05 |
| Equity (Book Value) | -2.63M |
| Book Value Per Share | -1.26 |
| Working Capital | -2.18M |
Cash Flow
| Operating Cash Flow | -8.92M |
| Capital Expenditures | n/a |
| Free Cash Flow | -8.92M |
| FCF Per Share | -$13.79 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BPTH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -62.56% |
| Shareholder Yield | -62.56% |
| Earnings Yield | -370.81% |
| FCF Yield | -236.90% |
Analyst Forecast
The average price target for BPTH is $30.00, which is 1,557.46% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.00 |
| Price Target Difference | 1,557.46% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 23, 2024. It was a reverse split with a ratio of 1:20.
| Last Split Date | Feb 23, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |